Jonathan David Schwartz - Chief Science & Gene Therapy Officer at ROCKET PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Science & Gene Therapy Officer
Issuer Symbol
RCKT, RCKTW on Nasdaq
All Insider Reports
All Insider Reports

Jonathan David Schwartz - trading volume in the past year for ROCKET PHARMACEUTICALS, INC.

Holdings reported by Jonathan David Schwartz for ROCKET PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 119,682 $1,800,017 $15.04 11 Feb 2025 Direct Common Stock
Common Stock 299,064 $892,107 $2.98 18 Nov 2025 Direct

Transactions reported by Jonathan David Schwartz for ROCKET PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.